Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Emtricitabine/tenofovir disoproxil fumarate (Truvada) and didanosine (Videx) are both antiretroviral (ARV) medications used to treat HIV when taken in combination with other HIV medications. They belong to the same subclass called nucleoside reverse transcriptase inhibitors (NRTIs), which help prevent the virus from making copies of itself. However, there are several differences between them. Truvada is a combination medication that is still available and is also used for HIV pre-exposure prophylaxis (PrEP), while Videx has been discontinued in the U.S. due to serious side effects and lack of demand. Truvada is taken once daily as a tablet, whereas Videx was also taken orally but is no longer available. Truvada is available as a generic, making it a more cost-effective option. Common side effects of Truvada include nausea, diarrhea, and dizziness, while Videx was known for more severe side effects, which contributed to its discontinuation. Additionally, Truvada requires regular monitoring of kidney and liver function, and it can interact with medications for hepatitis C, whereas Videx had restrictions on being taken with certain other HIV medications.
Truvada
Didanosine (Videx)
Truvada
Didanosine (Videx)
Summary of Truvada vs. Videx
Summary for HIV ARV Combo
Prescription only
Truvada, also known as TDF/FTC, is a combination medication that contains the antiretrovirals emtricitabine and tenofovir disoproxil fumarate. Truvada is used as part of an antiretroviral (ARV) regimen to treat HIV (human immunodeficiency virus) infections in adults and children. It's also preferred for HIV PrEP (pre-exposure prophylaxis or prevention). This medication works against HIV by stopping the virus from making copies of itself and spreading. Truvada tablets are taken by mouth once daily. Side effects when it's used for treating HIV include nausea, diarrhea, and dizziness. And Truvada side effects when used for PrEP include headache and belly pain.
Summary for HIV ARV
Didanosine (Videx) was one of the first HIV antiretroviral (ARV) medications approved by the FDA. It has a lot of serious side effects that have limited its use in recent years and is no longer available in the U.S.